A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the potential to protect humans from developing HIV infection and AIDS. This HIV ...
A drug commonly used to treat epilepsy could be repurposed to significantly boost the response to vaccines in humans, helping ...
An experimental HIV vaccine trained immune cells to generate broadly neutralizing HIV antibodies in primates. The findings ...
The review draws the formal regulatory distinction: gene therapy involves the deliberate and permanent alteration of a patient's genome. mRNA vaccines do not ...
It’s natural for parents to want to do everything they can to keep their children healthy. Most families attempt to protect ...
Moderna gains fresh market attention after a unanimous flu vaccine panel vote strengthens confidence in its mRNA vaccine ...
The conservative war on child health starts with the anti-vaccine campaign and proceeds to cutbacks in nutrition assistance ...
A contagious facial cancer has erased roughly 80% of Tasmania's wild devils since it surfaced in the 1990s, and biting, a ...
A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists, and IAVI has the ...
The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian ...
Highlights:Scientists at La Jolla Institute for Immunology and Scripps Research have developed an HIV vaccine that trains immune cells to see past ...
Drugmakers are working on a potential new shot to prevent the tick-borne illness. How might it fare in the era of vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results